Newsfeeds - Spark Newswire

1 minute read

Events
News

Akouos To Present At Jefferies Gene Therapy/Editing Summit

Today, 3:47 PM

Akouos, Inc. ("Akouos") (NASDAQ:AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that

AKUS

2 minute read

News

5 Value Stocks To Watch In The Healthcare Sector

By Benzinga Insights

Today, 3:47 PM

The Meaning Behind Value Stocks

AKUS

2 minute read

News

5 Value Stocks In The Healthcare Sector

By Benzinga Insights

Today, 3:47 PM

What Defines a Value Stock?

AKUS

11 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 3:47 PM

On Friday morning, 155 companies achieved new lows for the year.

AAU

6 minute read

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

By Shanthi Rexaline

Today, 3:47 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19)

ABVC

12 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 3:47 PM

Thursday morning, 173 companies reached new 52-week lows.

AAMC

3 minute read

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

By Shanthi Rexaline

Today, 3:47 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18)

ABBV

6 minute read

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios’ Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

By Shanthi Rexaline

Today, 3:47 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)

ABBV

1 minute read

Akouos Q2 EPS $(0.66) Up From $(11.14) YoY

By Benzinga Newsdesk

Today, 3:47 PM

Akouos (NASDAQ:AKUS) reported quarterly losses of $(0.66) per share. This is a 94.08 percent increase over losses of $(11.14) per share from the same period last year.

AKUS

1 minute read

Akouos’ Hearing Loss Gene Therapy Poised To Receive Orphan Drug Tag In Europe

By Vandana Singh

Today, 3:47 PM

The European Medicines Agency (EMA) Committee for Orphan Medicinal Products has issued a positive opinion on Akouos Inc’s (NASDAQ:AKUS) application for orphan…

AKUS